NEW YORK--(BUSINESS WIRE)--Aug 5, 2026--
Kindred Companion Sciences, a biotechnology company applying precision gene editing in companion animals, emerged from stealth today with a research publication in The CRISPR Journal.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805451804/en/
The peer-reviewed study, “Targeted genetic knockout of Can f 1, the major allergen in dogs,” describes a precise CRISPR-Cas9 edit in two female beagles, Alfie and Bailey. Born in September 2024, the dogs have shown healthy growth and development, and Can f 1 protein was not detected in saliva or dander, the two routes through which most people are exposed.
For millions of people – nearly one in eight Americans – allergies can make living with a dog impossible. The impact extends beyond companionship; dog allergies are linked to more than a million asthma attacks each year, while dog ownership has been associated with a range of physical, emotional, and social health benefits.
“Kindred was founded on the belief that people shouldn't have to choose between their health and the companionship of dogs,” said Matt Walker, PhD, CEO of Kindred Companion Sciences. “As someone who lives with dog allergies, this work is deeply personal. For most of my life, I assumed I'd never have a dog but have lived with Bailey for almost two years. She's a happy, healthy, and incredibly sweet dog who reminds me every day why this work matters.”
Data reported in The CRISPR Journal serve to demonstrate:
“These data help validate our approach, which addresses the allergen at its genetic source,” said Walker. “We’re hopeful that Alfie and Bailey will be the first of many Kindred dogs as we build carefully and responsibly toward the next generation of companion animals.”
Kindred dogs are not commercially available today. The genomic alteration described in this study is investigational and has not been approved by FDA.
Animal welfare is central to Kindred's approach. All dogs are bred, raised, and monitored under veterinary guidance, with long-term health, temperament, and quality of life as primary considerations. All animal procedures were carried out in accordance with applicable animal welfare regulations and established principles of responsible animal research.
About Kindred Companion Sciences
Kindred Companion Sciences is a biotechnology company using precision genome engineering to address allergies at their biological source. Founded in 2020 by Matt Walker, Ph.D. and Nick Gavin, Kindred’s mission is to expand access to dogs for allergy-sensitive households. Using CRISPR-Cas9, Kindred has eliminated Can f 1, the major dog allergen, in two dogs as described in a peer-reviewed study in The CRISPR Journal. Kindred is advancing its work through continued research and regulatory review. Learn more at kindredcompanion.com.
Born in September 2024, Alfie and Bailey have shown healthy growth and development, and Can f 1 protein was not detected in saliva or dander.
PHOENIX (AP) — Brett Sullivan hit a three-run homer in the second inning and the Colorado Rockies, despite walking 10 batters, held on to beat the Arizona Diamondbacks 6-4 on Wednesday.
Sullivan connected on a shot down the right-field line to cap a four-run inning against Arizona starter Merrill Kelly.
Zac Veen, in his first game of the season, added a two-run homer in the fourth for the Rockies. The 2020 first-round pick was called up earlier in the week. The Rockies won consecutive road games for the first time since June 1-2 at the Los Angeles Angels. That was also Colorado’s previous road series win.
Ryan Feltner (5-6) went five innings for the win. He gave up seven hits and two runs, walking three and striking out two.
Jordan Romano pitched the ninth for his 12th save.
Kelly (8-10) gave up six hits and six earned runs in five innings.
Corbin Carroll hit his 100th career home run, and 18th of the season, an opposite-field shot to left-center off lefty Brennan Bernardino in the eighth. Earlier, the Arizona All-Star hit his 14th triple of the season, twice as many as any other player has. His 57 career triples lead all active players.
The Diamondbacks stranded 15 baserunners, including the bases loaded in the fifth and sixth. In the sixth, Gabriel Moreno struck out looking in an at-bat that saw three of plate umpire Emil Jiménez’s calls overturned — two called strikes that were well out of the strike zone, and the final pitch was changed to a strike.
Of the 10 walks, only one Diamondback scored — on a bases-loaded walk.
Rockies: Off Thursday. LHP Kyle Freeland (3-10, 6.63 ERA) was set to starts Friday in San Francisco against Giants RHP Landen Roupp (7-11, 4.22).
Diamondbacks: Off Thursday. RHP Brandon Pfaadt (6-1, 3.36) was scheduled to start opposite Braves LHP Chris Sale (12-7, 2.20) on Friday in Atlanta.
AP MLB: https://apnews.com/hub/mlb
Arizona Diamondbacks' Ketel Marte (4) hits a run-scoring single as Colorado Rockies catcher Brett Sullivan reaches for the ball during the first inning of a baseball game, Wednesday, Aug. 12, 2026, in Phoenix. (AP Photo/Ross D. Franklin)
Colorado Rockies' Brett Sullivan (26) celebrates his three-run home run against the Arizona Diamondbacks with Rockies' Willi Castro (3) during the second inning of a baseball game, Wednesday, Aug. 12, 2026, in Phoenix. (AP Photo/Ross D. Franklin)
Colorado Rockies' Brett Sullivan, second from right, celebrates his three-run home run against the Arizona Diamondbacks with Rockies' Jake McCarthy (31), Mickey Moniak (22) and Willi Castro (3) during the second inning of a baseball game, Wednesday, Aug. 12, 2026, in Phoenix. (AP Photo/Ross D. Franklin)
Arizona Diamondbacks starting pitcher Merrill Kelly (29) gets a new baseball after giving up a three-run home run to Colorado Rockies' Brett Sullivan, right, during the second inning of a baseball game, Wednesday, Aug. 12, 2026, in Phoenix. (AP Photo/Ross D. Franklin)
Colorado Rockies' Brett Sullivan watches the flight of his three-run home run against the Arizona Diamondbacks during the second inning of a baseball game, Wednesday, Aug. 12, 2026, in Phoenix. (AP Photo/Ross D. Franklin)
